Gargi Nadkarni

Gargi Nadkarni is a seasoned professional in the pharmaceutical industry, currently serving as Portfolio Lead at Elpen Pharmaceutical Co. Inc. since December 2023. Previously, Gargi held the position of Senior Manager at Lotus Pharmaceutical Co., Ltd (formerly Alvogen) from June 2021 to December 2023 and at SUN PHARMA from May 2017 to June 2021, where responsibilities included product identification for ANDAs and 505(b)(2) applications, designing strategies aligned with business goals, and tracking competitor activity. With a robust background in intellectual property and regulatory affairs, Gargi has also contributed to various managerial roles within SUN PHARMA, beginning as an Assistant Manager in IPC Litigations in 2009 and advancing through multiple positions to develop strategies for non-infringement and support business development initiatives. Gargi’s educational qualifications include an M.Pharm.Sci. in Drug Delivery Technology and a Bachelor of Laws in Intellectual Property Law, complemented by diplomas in Patent Law.